Pluri Inc. (PLUR) stock
PLURNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
$0.97+0.05 (+5.98%)
Close on Nov 19, 2026Market cap $11.97MP/E –Yield –
Pluri free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Pluri's free cash flow for the twelve months ending Jun 30, 2026 was -$20.22M. For fiscal 2026 it was -$20.22M. The highest annual figure on record is -$4.76M in fiscal 2012.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | -$20.22M | – |
| FY2025 | Jun 30, 2025 | -$19.83M | – |
| FY2024 | Jun 30, 2024 | -$18.34M | – |
| FY2023 | Jun 30, 2023 | -$23.12M | – |
| FY2022 | Jun 30, 2022 | -$36.78M | – |
| FY2021 | Jun 30, 2021 | -$31.28M | – |
| FY2020 | Jun 30, 2020 | -$26.64M | – |
| FY2019 | Jun 30, 2019 | -$29.69M | – |
| FY2018 | Jun 30, 2018 | -$21.72M | – |
| FY2017 | Jun 30, 2017 | -$21.99M | – |
| FY2016 | Jun 30, 2016 | -$20.27M | – |
| FY2015 | Jun 30, 2015 | -$21.44M | – |
| FY2014 | Jun 30, 2014 | -$20.69M | – |
| FY2013 | Jun 30, 2013 | -$21.20M | – |
| FY2012 | Jun 30, 2012 | -$4.76M | – |
| FY2011 | Jun 30, 2011 | -$6.72M | – |
| FY2010 | Jun 30, 2010 | -$5.80M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | -$4.47M | – |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | -$4.56M | – |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | -$5.65M | – |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | -$5.54M | – |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | -$5.94M | – |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | -$4.88M | – |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | -$4.74M | – |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | -$4.27M | – |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | -$4.32M | – |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | -$4.29M | – |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | -$3.77M | – |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | -$5.96M | – |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | -$2.99M | – |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | -$6.10M | – |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | -$6.35M | – |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | -$7.68M | – |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | -$8.63M | – |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | -$9.46M | – |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | -$9.89M | – |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | -$8.80M | – |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | -$9.64M | – |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | -$7.45M | – |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | -$7.97M | – |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | -$6.22M | – |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | -$6.44M | – |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | -$6.53M | – |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | -$6.38M | – |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | -$7.30M | – |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | -$6.70M | – |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | -$6.03M | – |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | -$8.28M | – |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | -$8.69M | – |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | -$5.91M | – |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | -$5.61M | – |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | -$4.87M | – |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | -$5.34M | – |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | -$6.41M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | -$5.61M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | -$5.90M | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | -$4.07M | – |
See a number that looks wrong?